FDA Investigator: Lucila B. Nwatu

- Lucila B. Nwatu first started conducting FDA inspections in 2013, with the last inspection in 2024. Over that time, Lucila B. Nwatu has conducted 60 inspections at 55 companies across 58 sites.

Get Lucila Nwatu's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 BSO LLC, Lakewood | 2024

Out-of-stock
Lucila B. Nwatu
Human Drugs Form 483

FDA 483 Rpk Pharmaceuticals Inc, Union City | 2019

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Genentech, Inc., Vacaville | 2018

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Nature & Nature Co., Ltd., Gangnam | 2018

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Samsung Biologics Co., Ltd., Yeonsu | 2018

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Intersect ENT, Inc., Menlo Park | 2017

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Hi Tech Pharm Co., Ltd., Eumseong | 2017

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Cosmecca Korea Co., Ltd., Eumseong-Gun | 2017

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 TDS Pharm. Co., Ltd., Eumseong-Gun | 2017

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Cs Bio Company, Menlo Park | 2017

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483

FDA 483 Jazz Pharmaceuticals, Inc, Palo Alto | 2017

Out-of-stock
Lucila B. Nwatu
Human Drug Form 483